Antibacterial therapy for acute cystitis in the age of growing pathogen resistance


Acute cystitis refers to uncomplicated lower urinary tract infections, with the recurrence rates after the first cystitis episode being 50%. The basic treatment for the above diseases is antibacterial therapy, whose efficiency depends entirely on the right choice of a drug during initial empiric therapy. The paper gives the European Association of Urology guidelines and Russian guidelines, which are based on the results of both international (ARESC) and Russian (DARMIS) studies of urinary tract infection pathogens and their susceptibility to antibacterial drugs. Phosphomycin trometamol and furasidine potassium are the drugs of choice to treat acute cystitis in Russia now.

Full Text

Restricted Access

About the authors

L A Siniakova



  1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113 (Suppl 1A): 5S-13S.
  2. Naber K.G., Schito G., Botto H. et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008; 54 (5): 1164-1175.
  3. Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. N Engl J Med 1993; 329 (18): 1328-1334.
  4. Bradbury S.M. Collection of urine specimens in general practice: to clean or not to clean? J R Coll Gen Pract 1988; 38 (313): 363-365.
  5. Lifshitz E., Kramer L. Outpatient urine culture: does collection technique matter? Arch Intern Med 2000; 160 (16): 2537-2540.
  6. Foxman B., Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 2003; 17 (2): 227-241.
  7. Fihn S.D. Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med 2003; 349 (3): 259-266.
  8. Kunin C. Urinary tract infections. In: Detection, prevention and management. 5th ed. Philadelphia: Lea & Febiger 1997.
  9. Vouloumanou E.K., Karageorgopoulos D.E., Kazantzi M.S. et al. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect 2009; 64 (1): 16-24.
  10. Lecomte F., Allaert F.A. Single-dose treatment of cystitis with fosfomycin trometamol (Monuril): analysis of 15 comparative trials on 2,048 patients. Giorn It Ost Gin 1997; 19: 399-404.
  11. Nicolle L.E. Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother 2000; 46 (Suppl 1): 35-39; discussion 63-65.
  12. Gupta K., Hooton T.M., Roberts P.L., Stamm W.E. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007; 167 (20): 2207-2212.
  13. Warren J.W., Abrutyn E., Hebel J.R. et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29 (4): 745-758.
  14. Gupta K., Stamm W.E. Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. Int J Antimicrob Agents 2002; 19 (6): 554-556.
  15. Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А. Антимикробная терапия инфекций почек, мочевыводящих путей и мужских половых органов. Российские национальные рекомендации. М., 2014, 64 с.
  16. Reeves D.S. Fosfomycin trometamol. J Antimicrob Chemother 1994; 34: 853-858.
  17. Auer S., Wojna A., Hell M. Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-Β-Lactamase-Producing Escherichia coli. Antimicrobial Agents Chemother 2010; 54 (9): 4006-4008.
  18. Перепанова Т.С., Хазан П.Л. Применение нитрофуранов при инфекции мочевых путей. Эффективная фармакотер в урол 2007; 4: 20-30.
  19. Падейская Е.Н. Фурамаг в ряду антимикробных препаратов, производных 5-нитрофурана: знание для клинической практики. Инфек и антимикроб тер 2004; 1: 24-31.



Abstract - 24



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies